Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Business Update

Vilin Bio Med Business Update

Vilin Bio Med has signed an MOU with Ideal Pharma BV to distribute generic and branded medicines across Europe. The partnership utilizes Ideal Pharma's distribution infrastructure.

Source

NSE filing, NSE: VILINBIO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Vilin Bio Med Ltd: key numbers

Share price
₹52.05
Market cap
₹79.38 Cr
Revenue (annual)
₹42.26 Cr
Net profit (annual)
₹1.93 Cr
P/E (TTM)
41.1×Sector 45.9×
Promoter holding
56.65%+0.00% QoQ
FII holding
0.13%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Vilin Bio Med Ltd

All →

Other business update announcements

All →